These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 11378956)

  • 1. Therapeutic antibody production technologies: molecules, applications, expression and purification.
    Humphreys DP; Glover DJ
    Curr Opin Drug Discov Devel; 2001 Mar; 4(2):172-85. PubMed ID: 11378956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies and genetically engineered related molecules: production and purification.
    Roque AC; Lowe CR; Taipa MA
    Biotechnol Prog; 2004; 20(3):639-54. PubMed ID: 15176864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manufacturing of recombinant therapeutic proteins in microbial systems.
    Graumann K; Premstaller A
    Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biopharmaceuticals derived from genetically modified plants.
    Goldstein DA; Thomas JA
    QJM; 2004 Nov; 97(11):705-16. PubMed ID: 15496527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rapid discovery of engineered antibodies.
    Wang M; He M
    IDrugs; 2007 Aug; 10(8):562-5. PubMed ID: 17665332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downstream processing of recombinant proteins from transgenic feedstock.
    Nikolov ZL; Woodard SL
    Curr Opin Biotechnol; 2004 Oct; 15(5):479-86. PubMed ID: 15464381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in therapeutic glycoprotein production.
    Sethuraman N; Stadheim TA
    Curr Opin Biotechnol; 2006 Aug; 17(4):341-6. PubMed ID: 16828275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines to cell engineering for monoclonal antibody production.
    Rita Costa A; Elisa Rodrigues M; Henriques M; Azeredo J; Oliveira R
    Eur J Pharm Biopharm; 2010 Feb; 74(2):127-38. PubMed ID: 19853660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailor-made antibody therapeutics.
    Chowdhury PS; Wu H
    Methods; 2005 May; 36(1):11-24. PubMed ID: 15848071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bench to batch: advances in plant cell culture for producing useful products.
    Weathers PJ; Towler MJ; Xu J
    Appl Microbiol Biotechnol; 2010 Feb; 85(5):1339-51. PubMed ID: 19956945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioreactor technology: a novel industrial tool for high-tech production of bioactive molecules and biopharmaceuticals from plant roots.
    Sivakumar G
    Biotechnol J; 2006 Dec; 1(12):1419-27. PubMed ID: 17136730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in plant molecular farming.
    Obembe OO; Popoola JO; Leelavathi S; Reddy SV
    Biotechnol Adv; 2011; 29(2):210-22. PubMed ID: 21115109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant-based production of xenogenic proteins.
    Hood EE; Jilka JM
    Curr Opin Biotechnol; 1999 Aug; 10(4):382-6. PubMed ID: 10449314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affinity purification of a framework 1 engineered mouse/human chimeric IgA2 antibody from tobacco.
    Boes A; Spiegel H; Delbrück H; Fischer R; Schillberg S; Sack M
    Biotechnol Bioeng; 2011 Dec; 108(12):2804-14. PubMed ID: 21755499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody engineering and modification technologies.
    Filpula D
    Biomol Eng; 2007 Jun; 24(2):201-15. PubMed ID: 17466589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant polyclonal antibodies: therapeutic antibody technologies come full circle.
    Haurum J; Bregenholt S
    IDrugs; 2005 May; 8(5):404-9. PubMed ID: 15883923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant plasma proteins.
    Burnouf T
    Vox Sang; 2011 Jan; 100(1):68-83. PubMed ID: 21175657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of single-chain variable fragment antibodies in therapeutics and diagnostics.
    Weisser NE; Hall JC
    Biotechnol Adv; 2009; 27(4):502-20. PubMed ID: 19374944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody therapeutics, antibody engineering, and the merits of protein stability.
    Demarest SJ; Glaser SM
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):675-87. PubMed ID: 18729019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioreactor systems for the production of biopharmaceuticals from animal cells.
    Warnock JN; Al-Rubeai M
    Biotechnol Appl Biochem; 2006 Jul; 45(Pt 1):1-12. PubMed ID: 16764553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.